This website uses cookies to ensure you get the best experience
Lacopa news

Lacopa's portfolio of solutions has expanded with the Rigenerand brand.

Lacopa LLC has signed a cooperation agreement with the Italian company Rigenerand for distribution of a unique solution for 3D cell culture research.

VITVO it’s a ready to use, flat and handheld bioreactor, integrating scaffold for the establishment of in vitro 3D cell culture model that can be used for a large number of research applications and pre-clinical investigations. 

VITVO positioning between the in vitro high throughput screening and the in vivo models will reduce costs of drug screening improving the reliability of pre-clinical testing for safety (i.e. normal hepatocytes) and efficacy (i.e. cancer cell lines or primary tumor cells). This in vitro 3D cell culture technology offers also a solution for precision medicine approaches.